Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jul 2026 for ADC Therapeutics SA. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Mohamed Zaki: trading record in brief
Mohamed Zaki discloses dealings in ADC Therapeutics SA to SEC (Form 4). We count 5 filings; the first trade dates from 6 December 2024 and the latest from 30 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 2 July 2026, reports a share grant in ADC Therapeutics SA. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mohamed Zaki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
213,900 sharesCommon SharesSEC:0001628280-26-047036:0
285,200 shares@ US$3.9962.2% of flowCommon SharesSEC:0001628280-26-009282:0
41,068 shares@ US$3.297.5% of flowCommon SharesSEC:0001628280-25-056171:0
230,000 shares@ US$1.6123.1% of flowCommon SharesSEC:0001628280-25-005862:0
37,112 shares@ US$3.137.1% of flowCommon SharesSEC:0001628280-24-050543:0
5 of 5 declarations
